Literature DB >> 18625526

Risk of cardiovascular and cerebrovascular events after atrial fibrillation diagnosis.

Ana Ruigómez1, Saga Johansson, Mari-Ann Wallander, Nils Edvardsson, Luis Alberto García Rodríguez.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is associated with subsequent cardiovascular events including ischemic stroke, transient ischemic events, and coronary events. This study aimed to evaluate the risk of ischemic cerebrovascular events (ICVE), coronary events (CE) or heart failure (HF) following a diagnosis of AF.
METHODS: Patients were selected from the UK General Practice Research Database. The incidence of ICVE, CE and HF was determined during a 6-year follow-up period for patients with a first diagnosis of AF (n=831) and a control group without AF (n=8226). Relative risk of developing a cardiovascular event associated with prior AF and other potential risk factors was estimated using Cox regression analysis.
RESULTS: A first diagnosis of ICVE, CE or HF was made in 261 patients in the AF group and 622 in the control group. The relative risks associated with AF were 2.1 for CE (95% CI: 1.6-2.9), 3.0 for ICVE (95% CI: 2.3-4.0) and 6.4 for HF (95% CI: 5.0-8.3). The risks of CE, HF and ICVE were higher in patients with chronic AF than paroxysmal AF (odds ratio: 1.5, 95% CI: 1.0-2.2) and in patients aged at least 60 years or with diabetes. Lifestyle factors did not significantly affect the risk of cardiovascular events in patients with AF.
CONCLUSIONS: After a first episode of AF there is an increased risk of ICVE, CE and HF. Patients initially diagnosed with chronic AF have a higher risk than those with paroxysmal AF.

Entities:  

Mesh:

Year:  2008        PMID: 18625526     DOI: 10.1016/j.ijcard.2008.04.050

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  11 in total

1.  Impact of race and gender on clinical outcomes of catheter ablation in patients with atrial fibrillation.

Authors:  Abdallah Bukari; Hemal Nayak; Zaid Aziz; Amrish Deshmukh; Roderick Tung; Cevher Ozcan
Journal:  Pacing Clin Electrophysiol       Date:  2017-09-20       Impact factor: 1.976

2.  Updated Geriatric Cardiology Guidelines of the Brazilian Society of Cardiology - 2019.

Authors:  Gilson Soares Feitosa-Filho; José Maria Peixoto; José Elias Soares Pinheiro; Abrahão Afiune Neto; Afonso Luiz Tavares de Albuquerque; Álvaro César Cattani; Amit Nussbacher; Ana Amelia Camarano; Angela Hermínia Sichinels; Antonio Carlos Sobral Sousa; Aristóteles Comte de Alencar Filho; Claudia F Gravina; Dario Celestino Sobral Filho; Eduardo Pitthan; Elisa Franco de Assis Costa; Elizabeth da Rosa Duarte; Elizabete Viana de Freitas; Emilio Hideyuki Moriguchi; Evandro Tinoco Mesquita; Fábio Fernandes; Gilson Soares Feitosa; Humberto Pierre; Ilnei Pereira Filho; Izo Helber; Jairo Lins Borges; Jéssica Myrian de Amorim Garcia; José Antonio Gordillo de Souza; José Carlos da Costa Zanon; Josmar de Castro Alves; Kalil Lays Mohallem; Laura Mariana de Siqueira Mendonça Chaves; Lídia Ana Zytynski Moura; Márcia Cristina Amélia da Silva; Maria Alice de Vilhena Toledo; Maria Elisa Lucena Sales de Melo Assunção; Mauricio Wajngarten; Mauro José Oliveira Gonçalves; Neuza Helena Moreira Lopes; Nezilour Lobato Rodrigues; Paulo Roberto Pereira Toscano; Pedro Rousseff; Ricardo Antonio Rosado Maia; Roberto Alexandre Franken; Roberto Dischinger Miranda; Roberto Gamarski; Ronaldo Fernandes Rosa; Silvio Carlos de Moraes Santos; Siulmara Cristina Galera; Stela Maris da Silva Grespan; Teresa Cristina Rogerio da Silva; William Antonio de Magalhães Esteves
Journal:  Arq Bras Cardiol       Date:  2019-06-06       Impact factor: 2.000

Review 3.  Peripheral artery disease and atrial fibrillation: a potentially dangerous combination.

Authors:  Francesco Violi; Gregory Y H Lip; Stefania Basili
Journal:  Intern Emerg Med       Date:  2011-06-11       Impact factor: 3.397

Review 4.  Thromboembolic risk and effect of oral anticoagulation according to atrial fibrillation patterns: A systematic review and meta-analysis.

Authors:  Alessio Lilli; Andrea Di Cori; Valerio Zacà
Journal:  Clin Cardiol       Date:  2017-05-04       Impact factor: 2.882

Review 5.  Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis.

Authors:  Vidar Ruddox; Irene Sandven; John Munkhaugen; Julie Skattebu; Thor Edvardsen; Jan Erik Otterstad
Journal:  Eur J Prev Cardiol       Date:  2017-06-15       Impact factor: 7.804

6.  Atrial fibrillation as a prognostic indicator of myocardial infarction and cardiovascular death: a systematic review and meta-analysis.

Authors:  Wenqi He; Yingjie Chu
Journal:  Sci Rep       Date:  2017-06-13       Impact factor: 4.379

7.  Thromboembolic risks associated with paroxysmal and persistent atrial fibrillation in Asian patients: a report from the Chinese atrial fibrillation registry.

Authors:  Ying Wang; Chang-Sheng Ma; Xin Du; Liu He; Jie Li; Guo-Hong Wang; Dan Wen; Jian-Zeng Dong; Jian-Hong Pan; Gregory Y H Lip
Journal:  BMC Cardiovasc Disord       Date:  2019-11-27       Impact factor: 2.298

8.  Population-based cohort study of warfarin-treated patients with atrial fibrillation: incidence of cardiovascular and bleeding outcomes.

Authors:  Arlene M Gallagher; Tjeerd P van Staa; Tarita Murray-Thomas; Nils Schoof; Andreas Clemens; Diana Ackermann; Dorothee B Bartels
Journal:  BMJ Open       Date:  2014-01-27       Impact factor: 2.692

Review 9.  Stroke Event Rates and the Optimal Antithrombotic Choice of Patients With Paroxysmal Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Yicong Chen; Yuhui Zhao; Ge Dang; Fubing Ouyang; Xinran Chen; Jinsheng Zeng
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

Review 10.  Atrial Fibrillation Mechanisms and Implications for Catheter Ablation.

Authors:  Ghassen Cheniti; Konstantinos Vlachos; Thomas Pambrun; Darren Hooks; Antonio Frontera; Masateru Takigawa; Felix Bourier; Takeshi Kitamura; Anna Lam; Claire Martin; Carole Dumas-Pommier; Stephane Puyo; Xavier Pillois; Josselin Duchateau; Nicolas Klotz; Arnaud Denis; Nicolas Derval; Pierre Jais; Hubert Cochet; Meleze Hocini; Michel Haissaguerre; Frederic Sacher
Journal:  Front Physiol       Date:  2018-10-17       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.